Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Obefazimod

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Abivax Presents 8-Week ABTECT Trial Results With Safety Update
    Abivax Presents 8-Week ABTECT Trial Results With Safety Update

    05 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/05/3161328/0/en/Abivax-Announces-Late-Breaking-Presentation-of-8-Week-ABTECT-Trial-Results-with-Updated-Safety-Data.html

    GLOBENEWSWIRE
    05 Oct 2025
    Share Share
    Abivax To Present Late-Breaking Abtect Phase 3 Data At 2025 UEG
    Abivax To Present Late-Breaking Abtect Phase 3 Data At 2025 UEG

    29 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/29/3158107/0/en/Abivax-Announces-Acceptance-of-Additional-Late-Breaking-Abstract-from-the-ABTECT-Phase-3-Induction-Trials-to-be-Presented-at-2025-United-European-Gastroenterology-UEG-Meeting.html

    GLOBENEWSWIRE
    29 Sep 2025
    Share Share
    Abivax Presents Obefazimod ABTECT Ph 3 Trials at 2025 UEG Meeting
    Abivax Presents Obefazimod ABTECT Ph 3 Trials at 2025 UEG Meeting

    23 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/23/3155082/0/en/Abivax-Announces-Presentation-of-Late-Breaking-Abstract-for-Obefazimod-from-the-ABTECT-Phase-3-Induction-Trials-at-2025-United-European-Gastroenterology-UEG-Meeting.html

    GLOBENEWSWIRE
    23 Sep 2025
    Share Share
    Abivax Reveals Ph3 Results for Obefazimod in Ulcerative Colitis
    Abivax Reveals Ph3 Results for Obefazimod in Ulcerative Colitis

    22 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/22/3119843/0/en/Abivax-Announces-Positive-Phase-3-Results-from-Both-ABTECT-8-Week-Induction-Trials-Investigating-Obefazimod-its-First-in-Class-Oral-miR-124-Enhancer-in-Moderate-to-Severely-Active-.html

    GLOBENEWSWIRE
    22 Jul 2025
    Share Share
    Abivax Presents 7 Abstracts On Obefazimod In Ulcerative Colitis
    Abivax Presents 7 Abstracts On Obefazimod In Ulcerative Colitis

    23 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/23/3014599/0/en/Abivax-Announces-Presentation-of-Seven-Abstracts-for-Obefazimod-in-Ulcerative-Colitis-at-2025-European-Crohn-s-and-Colitis-Organization-20th-Annual-Congress.html

    GLOBENEWSWIRE
    23 Jan 2025
    Share Share
    Abivax Enrolls 1st Patient In ENHANCE-CD Trial For Crohn's Disease
    Abivax Enrolls 1st Patient In ENHANCE-CD Trial For Crohn's Disease

    03 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/03/2958005/0/en/Abivax-Announces-First-Patient-Enrolled-in-ENHANCE-CD-the-Phase-2b-Trial-of-Obefazimod-in-Crohn-s-Disease.html

    GLOBENEWSWIRE
    03 Oct 2024
    Share Share